Table 2.
Clinical outcomes according to G8 score in patients treated with chemotherapy.
| All patients (n = 143), n (%) | With G8 >14 (n = 14), n (%) |
With G8 ≤14 (n = 129), n (%) |
OR (95%CI) |
|
|---|---|---|---|---|
| DR at start | 55 (38.5) | 3 (21.4) | 51 (39.5) | 2.44 (0.65–9.19) |
| DR during CT | 109 (76.2) | 12 (85.7) | 96 (74.4) | 0.49 (0.1–2.3) |
| SAEs | 74 (51.7) | 6 (42.9) | 68 (52.7) | 1.51 (0.5–4.59) |
| Hematological SAEs | 37 (25.9) | 4 (28.6) | 33 (25.6) | 0.86 (0.25–2.93) |
| Non-hematological SAEs | 37 (25.9) | 3 (21.4) | 34 (26.4) | 1.31 (0.35–4.99) |
| Discontinuation | 25 (17.5) | 0 (0.0) | 25 (19.4) | – |
-, not applicable; G8, geriatric 8; CT, chemotherapy; DR, dose reduction; SAEs, serious adverse events; OR, odds ratio; CI, confidence interval.